泪点阻塞治疗干眼症:Cochrane系统综述摘要
本文为Cochrane系统综述摘要,评估泪点塞治疗干眼的有效性,纳入10项随机或半随机试验,主要结局为2-12个月症状改善。与观察相比泪点塞在2个月时干眼症状评分更低,与人工泪液相比在3个月时报告更多症状改善,但其余比较未显示有意义的差异,总体证据不确定。
要点
- 与观察相比,泪点塞在2个月时干眼症状评分更低(MD -28.20分,95%CI -33.61至-22.79)。
- 与人工泪液相比,泪点塞组在3个月时报告更多症状改善(MD -4.20分,95%CI -5.87至-2.53)。
- 其余比较(不同类型泪点塞、与环孢素或毛果芸香碱比较)未报告有临床或统计学意义的症状改善差异。
核心结论
- 泪点塞对干眼症状和常见体征的有效性尚无定论。
- 泪点塞类型、干眼类型与严重程度及试验方法的异质性妨碍做出明确结论。
研究设计与样本
- Cochrane系统综述,纳入随机和半随机试验,检索9个数据库,无日期或语言限制,由两名作者评估质量并提取数据。
- 共纳入10项试验,主要结局为2-12个月的症状改善。
主要发现
- 两项泪点塞与观察对比的试验中,泪点塞组干燥症状更少;2个月时干眼症状评分MD为-28.20分(95%CI -33.61至-22.79,量表范围0至105,一项试验)。
- 三项试验比较泪点塞与人工泪液;两项试验汇总分析中,泪点塞组在3个月时报告更多症状改善(MD -4.20分,95%CI -5.87至-2.53,量表范围0至6)。
- 其余五项试验比较泪点塞放置、丙烯酸与硅胶泪点塞、或泪点塞与环孢素或毛果芸香碱,均未报告有临床或统计学意义的症状改善差异(2-12个月)。
关键数值与推荐
- 主要结局为2-12个月的症状改善。
- 泪点塞与观察对比:2个月干眼症状评分MD -28.20分(95%CI -33.61至-22.79,量表0至105,一项试验)。
- 泪点塞与人工泪液对比:3个月症状改善MD -4.20分(95%CI -5.87至-2.53,量表0至6,两项试验汇总)。
临床怎么用
- 泪点塞可能改善干眼症状,但证据不确定,临床决策需结合患者具体情况。
- 不同泪点塞类型及干眼类型的效果差异尚不明确,选择时需考虑异质性。
局限性
- 泪点塞类型、干眼类型与严重程度及试验方法的异质性妨碍做出明确结论。
- 部分比较仅基于少量试验,证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dry eye disease is a disorder of the tear film associated with ocular signs and symptoms. Punctal occlusion aids the preservation of natural tears. We conducted a Cochrane systematic review to assess the effectiveness of punctal plugs for managing dry eye. Randomised and quasi-randomised trials were included. The primary outcome was symptomatic improvement (SI) at 2-12 months. Nine databases were searched with no date or language restrictions. Two authors assessed trial quality and extracted data. Summary risk ratios and mean differences were calculated. Ten trials were included. In two trials of punctal plugs versus observation, there was less dryness with punctal plugs. The mean difference (MD) in the dry eye symptom score at 2 months was -28.20 points (95% CI -33.61 to -22.79, range 0 to 105, one trial). Three trials compared punctal plugs with artificial tears. In a pooled analysis of two trials, punctal plug participants reported more SI at 3 months than artificial tear participants (MD -4.20 points, 95% CI -5.87 to -2.53, scales varied from 0 to 6). In the remaining five trials comparing punctal plug placement, acrylic and silicone plugs, or comparing plugs with cyclosporine or pilocarpine, none of the investigators reported a clinically or statistically meaningful difference in symptomatic improvement at 2-12 months. The effectiveness of punctal plugs for treating dry eye symptoms and common signs are inconclusive. Heterogeneity in the type of punctal plug, type and severity of dry eye being treated, and trial methodology confounds the ability to make decisive statements regarding the effectiveness of punctal plugs.
引用
- Ervin AM, Law A, Pucker AD, et al. Punctal occlusion for dry eye syndrome: summary of a Cochrane systematic review. Br J Ophthalmol. 2018. PMID: 30337332. doi:10.1136/bjophthalmol-2018-313267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。